A First-in-Human Single and Multiple Ascending Dose Study of MT-251

NCT07423299 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MT-251

Sponsor

Mirador Therapeutics, Inc.